HomeCompareCBPI vs EQR

CBPI vs EQR: Dividend Comparison 2026

CBPI yields 1810.63% · EQR yields 5.87%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 CBPI wins by $3948537007.78M in total portfolio value
10 years
CBPI
CBPI
● Live price
1810.63%
Share price
$0.07
Annual div
$1.23
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$3948537007.82M
Annual income
$3,561,590,338,763,862.00
Full CBPI calculator →
EQR
EQR
● Live price
5.87%
Share price
$59.15
Annual div
$3.47
5Y div CAGR
15.8%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$47.8K
Annual income
$5,475.61
Full EQR calculator →

Portfolio growth — CBPI vs EQR

📍 CBPI pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCBPIEQR
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, CBPI + EQR cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
CBPI pays
EQR pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CBPI
Annual income on $10K today (after 15% tax)
$153,903.87/yr
After 10yr DRIP, annual income (after tax)
$3,027,351,787,949,282.50/yr
EQR
Annual income on $10K today (after 15% tax)
$499.01/yr
After 10yr DRIP, annual income (after tax)
$4,654.27/yr
At 15% tax rate, CBPI beats the other by $3,027,351,787,944,628.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CBPI + EQR for your $10,000?

CBPI: 50%EQR: 50%
100% EQR50/50100% CBPI
Portfolio after 10yr
$1974268503.94M
Annual income
$1,780,795,169,384,668.80/yr
Blended yield
90.20%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on EQR right now

CBPI
No analyst data
EQR
Analyst Ratings
16
Buy
28
Hold
2
Sell
Consensus: Hold
Price Target
$70.35
+18.9% upside vs current
Range: $63.00 — $78.50
Altman Z
1.8
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CBPI buys
0
EQR buys
0
No recent congressional trades found for CBPI or EQR in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCBPIEQR
Forward yield1810.63%5.87%
Annual dividend / share$1.23$3.47
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%15.8%
Portfolio after 10y$3948537007.82M$47.8K
Annual income after 10y$3,561,590,338,763,862.00$5,475.61
Total dividends collected$3920850870.10M$23.0K
Payment frequencyquarterlyquarterly
SectorStockREIT

Year-by-year: CBPI vs EQR ($10,000, DRIP)

YearCBPI PortfolioCBPI Income/yrEQR PortfolioEQR Income/yrGap
1← crossover$191,763$181,063.38$11,380$679.82+$180.4KCBPI
2$3,450,171$3,244,983.80$13,014$837.25+$3.44MCBPI
3$58,255,362$54,563,679.04$14,961$1,036.20+$58.24MCBPI
4$923,357,120$861,023,883.33$17,297$1,289.22+$923.34MCBPI
5$13,742,544,470$12,754,552,351.01$20,121$1,613.15+$13742.52MCBPI
6$192,114,847,589$177,410,325,006.05$23,561$2,030.84+$192114.82MCBPI
7$2,523,431,920,604$2,317,869,033,684.31$27,783$2,573.54+$2523431.89MCBPI
8$31,153,577,527,643$28,453,505,372,596.96$33,013$3,284.39+$31153577.49MCBPI
9$361,632,400,990,033$328,298,073,035,454.30$39,547$4,223.51+$361632400.95MCBPI
10$3,948,537,007,823,197$3,561,590,338,763,862.00$47,791$5,475.61+$3948537007.78MCBPI

CBPI vs EQR: Complete Analysis 2026

CBPIStock

China Botanic Pharmaceutical Inc. does not have significant operations. It intends to explore and identify business opportunities within the United States, including a potential acquisition of an operating entity through a reverse merger, asset purchase, or similar transaction. The company was formerly known as Renhuang Pharmaceuticals, Inc. and changed its name to China Botanic Pharmaceutical Inc. in November 2010. China Botanic Pharmaceutical Inc. was incorporated in 1988 and is based in New York, New York.

Full CBPI Calculator →

EQRREIT

Equity Residential is committed to creating communities where people thrive. The Company, a member of the S&P 500, is focused on the acquisition, development and management of residential properties located in and around dynamic cities that attract high quality long-term renters. Equity Residential owns or has investments in 305 properties consisting of 78,568 apartment units, located in Boston, New York, Washington, D.C., Seattle, San Francisco, Southern California and Denver.

Full EQR Calculator →
📬

Get this CBPI vs EQR comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CBPI vs SCHDCBPI vs JEPICBPI vs OCBPI vs KOCBPI vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.